Earnings Per Share
EPS (Basic)
AbbVie EPS (Basic) decreased by 61.8% to $0.39 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 45.8%, from $0.72 to $0.39. Over 4 years (FY 2021 to FY 2025), EPS (Basic) shows a downward trend with a -22.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionEarnings Per Share
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 8, 2026
How to read this metric
Higher values indicate better profitability per share, which is generally favorable for stock price performance.
Detailed definition
Calculated by dividing net income available to common shareholders by the weighted-average number of common shares outst...
Peer comparison
Standard metric used by all public companies to report earnings performance to shareholders.
Metric ID:
eps_basicHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.42 | $1.78 | $2.27 | $2.52 | $0.52 | $2.22 | $1.39 | $0.13 | $1.14 | $1.00 | $0.46 | $0.77 | $0.77 | $0.88 | -$0.02 | $0.72 | $0.52 | $0.10 | $1.02 | $0.39 |
| QoQ Change | — | +323.8% | +27.5% | +11.0% | -79.4% | +326.9% | -37.4% | -90.6% | +776.9% | -12.3% | -54.0% | +67.4% | +0.0% | +14.3% | -102.3% | >999% | -27.8% | -80.8% | +920.0% | -61.8% |
| YoY Change | — | — | — | — | +23.8% | +24.7% | -38.8% | -94.8% | +119.2% | -55.0% | -66.9% | +492.3% | -32.5% | -12.0% | -104.3% | -6.5% | -32.5% | -88.6% | >999% | -45.8% |
Range-$0.02 – $2.52
CAGR-1.5%
Avg YoY Growth+330.1%
Median YoY Growth-32.5%
EPS (Basic) at Other Companies
Frequently Asked Questions
- What is AbbVie's eps (basic)?
- AbbVie (ABBV) reported eps (basic) of $0.39 in Q1 2026.
- How has AbbVie's eps (basic) changed year-over-year?
- AbbVie's eps (basic) decreased by 45.8% year-over-year, from $0.72 to $0.39.
- What is the long-term trend for AbbVie's eps (basic)?
- Over 4 years (2021 to 2025), AbbVie's eps (basic) has grown at a -22.3% compound annual growth rate (CAGR), from $6.47 to $2.36.
- What does eps (basic) mean?
- The portion of a company's profit allocated to each share of common stock.